Compare Crestchem with Similar Stocks
Stock DNA
Specialty Chemicals
INR 28 Cr (Micro Cap)
12.00
41
1.09%
-0.13
27.51%
3.40
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Aug-13-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Crestchem Ltd Investment Rating Upgraded to Sell Amid Mixed Technical and Financial Signals
Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 Apr 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing challenges in financial performance and valuation metrics. Investors should consider the detailed analysis across quality, valuation, financial trends, and technical indicators before making decisions.
Read full news article
Crestchem Ltd Downgraded to Strong Sell Amid Weak Technicals and Financial Performance
Crestchem Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 13 April 2026. The revision reflects a combination of deteriorating technical indicators, flat financial performance, and disappointing returns relative to benchmarks, signalling heightened caution for investors.
Read full news article
Crestchem Ltd Upgraded to Sell by MarketsMOJO Amid Mixed Technical and Financial Signals
Crestchem Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 April 2026. This change reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite persistent challenges in financial performance and long-term returns, technical indicators have shown signs of mild improvement, prompting a cautious upgrade in the stock’s outlook.
Read full news article Announcements 
Disclosure Under Regulation 30 (1) & 30 (2) Of SEBI ( SAST) Regulations2011
03-Apr-2026 | Source : BSEDear Sir Please find attached herewith Disclosure under Regulation 30(1) & 30 (2) of SEBI ( Substantial Acquisition of Shares & Takeovers) Regulation 2011 with Annexure A AND Disclosure under Regulation 31(4) of SEBI ( Substantial Acquisition of Shares & Takeovers) Nitin S.Shah
Board Meeting Outcome for Out Of Board Meeting Dated 31-03-2026
31-Mar-2026 | Source : BSEDear Sir File attached with.
Closure of Trading Window
26-Mar-2026 | Source : BSEDear Sir Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulation2015 as amended from time to time the Code of Conduct to regulate monitor and report trading by insiders of Crestchem Limited we hereby inform you that the trading window for dealing the Securities of the Company Shall remain closed from 1st April2026 to till 48 hours after the announcement of Audited financial results for the fourth quarter and year ended on 31st March2026 for all designated personsdirectors/KMP and other designated employees their relatives etc.covered under the Code from time to time. This is for your information. Nitin S.Shah Company Secretary
Corporate Actions 
No Upcoming Board Meetings
Crestchem Ltd has declared 10% dividend, ex-date: 13 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Mr. Dipak Narendraprasad Patel (29.2%)
None
65.99%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -0.42% vs 42.94% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 33.33% vs 54.29% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -6.36% vs 57.80% in Sep 2024
Growth in half year ended Sep 2025 is -44.03% vs 178.95% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 8.57% vs 14.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -23.70% vs 42.57% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 17.97% vs 27.08% in Mar 2024
YoY Growth in year ended Mar 2025 is 26.98% vs 211.59% in Mar 2024






